Clinical Trials Directory

Trials / Completed

CompletedNCT01429857

Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure

Status
Completed
Phase
Study type
Observational
Enrollment
304 (actual)
Sponsor
University Hospital, Saarland · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the prognostic value of admission high-sensitivity troponin in patients with acute decompensated heart failure.

Detailed description

Patients admitted for acute decompensated heart failure are included in the study. After gaining informed consent, concentrations of high-sensitivity troponin on admission and on discharge are assessed. 6 months after discharged, the incidence of clinical endpoint (mortality of all cause and of cardiovascular cause, hospitalization) is assessed by telephone contact to the patient and/or the physician. The aim of the study is to investigate the prognostic value of high-sensitivity troponin concentration for predicting death and re-hospitalization.

Conditions

Timeline

Start date
2010-06-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2011-09-07
Last updated
2013-06-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01429857. Inclusion in this directory is not an endorsement.